|
[1]
|
Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder
Frontiers in Oncology,
2023
DOI:10.3389/fonc.2023.1208089
|
|
|
|
|
[2]
|
Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics
Computers in Biology and Medicine,
2022
DOI:10.1016/j.compbiomed.2022.105996
|
|
|
|
|
[3]
|
Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics
Computers in Biology and Medicine,
2022
DOI:10.1016/j.compbiomed.2022.105996
|
|
|
|
|
[4]
|
Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN
Cancers,
2020
DOI:10.3390/cancers12082038
|
|
|
|
|
[5]
|
Risk of Inflammatory Bowel Disease in Patients with Chronic Myeloproliferative Neoplasms: A Danish Nationwide Cohort Study
Cancers,
2020
DOI:10.3390/cancers12092700
|
|
|
|
|
[6]
|
Integrative Approaches to Managing Myeloproliferative Neoplasms: the Role of Nutrition, Exercise, and Psychological Interventions
Current Hematologic Malignancy Reports,
2019
DOI:10.1007/s11899-019-00516-w
|
|
|
|
|
[7]
|
V617F‐independent upregulation of
JAK2
gene expression in patients with inflammatory bowel disease
Journal of Cellular Biochemistry,
2019
DOI:10.1002/jcb.28844
|
|
|
|
|
[8]
|
The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies
Cancers,
2018
DOI:10.3390/cancers10040104
|
|
|
|